Mild Cognitive Impairment (MCI) and REM Behavior Disorder (RBD) are both associated with a degeneration of ponto-medullary cholinergic pathways.
Brunetti, V., Losurdo, A., Testani, E., Lapenta, L., Mariotti, P., Marra, C., Rossini, P. M., Della Marca, G., Rivastigmine for refractory REM behavior disorder in mild cognitive impairment, <<CURRENT ALZHEIMER RESEARCH>>, 2014; 11 (3): 267-273. [doi:10.2174/1567205011666140302195648] [http://hdl.handle.net/10807/61177]
Rivastigmine for refractory REM behavior disorder in mild cognitive impairment
Brunetti, Valerio;Losurdo, Anna;Testani, Elisa;Mariotti, Paolo;Marra, Camillo;Rossini, Paolo Maria;Della Marca, Giacomo
2014
Abstract
Mild Cognitive Impairment (MCI) and REM Behavior Disorder (RBD) are both associated with a degeneration of ponto-medullary cholinergic pathways.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
